Involvement of sialoglycans in SARS‐COV ‐2 infection: opportunities and challenges for glyco‐based inhibitors - ANR - Agence nationale de la recherche Accéder directement au contenu
Article Dans Une Revue IUBMB Life Année : 2022

Involvement of sialoglycans in SARS‐COV ‐2 infection: opportunities and challenges for glyco‐based inhibitors

Résumé

Viral infections have been the causes of global pandemics, including the ongoing coronavirus disease 2019, which prompted the investigation into the infection mechanisms to find treatment and aid the vaccine design. Betacoronaviruses use spike glycoprotein on their surface to bind to host receptors, aiding their host attachment and cell fusion. Protein-glycan interaction has been implicated in the viral entry mechanism of many viruses and has recently been shown in SARS-CoV-2. Here, we reviewed the current knowledge on protein-glycan interactions that facilitate SARS-CoV-2 host entry, with special interest in sialoglycans present on both the virions and host cell surfaces. We also analyze how such information provides opportunities and challenges in glyco-based inhibitors.

Domaines

Chimie
Fichier principal
Vignette du fichier
NeucAc_Covid_HAL.pdf (739.52 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03850143 , version 1 (12-11-2022)

Identifiants

Citer

Sakonwan Kuhaudomlarp, Anne Imberty. Involvement of sialoglycans in SARS‐COV ‐2 infection: opportunities and challenges for glyco‐based inhibitors. IUBMB Life, 2022, ⟨10.1002/iub.2692⟩. ⟨hal-03850143⟩
42 Consultations
36 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More